Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syntho Pharmaceuticals, Inc. is a family-owned specialty pharmaceutical company based in Farmingdale, New York, focused on the development, manufacturing, and commercialization of branded and generic prescription drugs. Founded in 1999 by Muhammed and Hosneara Malik, the company operates an FDA-registered and DEA-licensed facility specializing in solid oral dosage forms. Its product portfolio primarily targets women's health and respiratory conditions, featuring hormone replacement therapies like Esterified Estrogens and Methyltestosterone (EEMT) and a range of cough, cold, and allergy medications such as Ed A Hist and Giltuss. In addition to its own product line, Syntho provides contract manufacturing and packaging services, leveraging its expertise in quality control and regulatory compliance. The company is recognized for its long-standing presence in the specialty pharma sector and its commitment to maintaining high-quality manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syntho Pharmaceuticals.